> top > docs > PMC:7113449 > annotations

PMC:7113449 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 0-8 Disease denotes COVID-19 MESH:C000657245
3 45-61 Disease denotes Hypersensitivity MESH:D004342
14 598-645 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
15 647-657 Species denotes SARS-CoV-2 Tax:2697049
16 803-811 Chemical denotes steroids MESH:D013256
17 79-103 Disease denotes coronavirus disease 2019 MESH:C000657245
18 105-113 Disease denotes COVID-19 MESH:C000657245
19 487-495 Disease denotes COVID-19 MESH:C000657245
20 857-865 Disease denotes COVID-19 MESH:C000657245
21 909-918 Disease denotes pneumonia MESH:D011014
22 969-978 Disease denotes pneumonia MESH:D011014
23 1013-1022 Disease denotes mortality MESH:D003643
25 1157-1165 Disease denotes COVID-19 MESH:C000657245
28 1214-1223 Disease denotes pneumonia MESH:D011014
29 1332-1341 Disease denotes pneumonia MESH:D011014
33 1420-1426 Species denotes people Tax:9606
34 1350-1359 Disease denotes Pneumonia MESH:D011014
35 1491-1509 Disease denotes pulmonary fibrosis MESH:D011658
37 1540-1547 Chemical denotes steroid MESH:D013256
42 1624-1632 Species denotes patients Tax:9606
43 1638-1646 Disease denotes COVID-19 MESH:C000657245
44 1726-1754 Disease denotes hypersensitivity pneumonitis MESH:D000542
45 1776-1791 Disease denotes viral pneumonia
47 1798-1826 Disease denotes Hypersensitivity pneumonitis MESH:D000542
50 2414-2427 Species denotes coronaviruses Tax:11118
51 2450-2459 Disease denotes pneumonia MESH:D011014
55 2670-2680 Species denotes SARS-CoV-2 Tax:2697049
56 2701-2709 Species denotes SARS CoV Tax:694009
57 2749-2760 Disease denotes pneumonitis MESH:D011014
59 3211-3219 Disease denotes COVID-19 MESH:C000657245
75 3781-3788 Species denotes patient Tax:9606
76 3961-3971 Species denotes SARS-CoV-2 Tax:2697049
77 4058-4066 Species denotes patients Tax:9606
78 4154-4182 Species denotes Human Immunodeficiency Virus Tax:12721
79 4184-4187 Species denotes HIV Tax:12721
80 4240-4243 Species denotes HIV Tax:12721
81 4300-4303 Species denotes HIV Tax:12721
82 4329-4344 Chemical denotes dextran sulfate MESH:D016264
83 4509-4516 Chemical denotes steroid MESH:D013256
84 4586-4593 Chemical denotes steroid MESH:D013256
85 3734-3742 Disease denotes COVID-19 MESH:C000657245
86 4031-4040 Disease denotes pneumonia MESH:D011014
87 4049-4057 Disease denotes COVID-19 MESH:C000657245
88 4563-4571 Disease denotes COVID-19 MESH:C000657245
89 4701-4719 Disease denotes pulmonary fibrosis MESH:D011658

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 404-408 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T2 1686-1690 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T3 2523-2541 Body_part denotes regulatory T cells http://purl.org/sig/ont/fma/fma84070
T4 2536-2541 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T5 4131-4141 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T6 4184-4187 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T7 4240-4243 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T8 4300-4303 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T9 4443-4447 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T10 4883-4887 Body_part denotes eyes http://purl.org/sig/ont/fma/fma54448

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1686-1690 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 0-8 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 45-73 Disease denotes Hypersensitivity Pneumonitis http://purl.obolibrary.org/obo/MONDO_0004553|http://purl.obolibrary.org/obo/MONDO_0017853
T4 45-61 Disease denotes Hypersensitivity http://purl.obolibrary.org/obo/MONDO_0000605|http://purl.obolibrary.org/obo/MONDO_0005271
T6 79-103 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T7 105-113 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 487-495 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 598-645 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T10 598-631 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T11 647-655 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T12 857-865 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 909-918 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T14 969-978 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T15 1157-1165 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 1214-1223 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T17 1332-1341 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T18 1350-1359 Disease denotes Pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T19 1491-1509 Disease denotes pulmonary fibrosis http://purl.obolibrary.org/obo/MONDO_0002771
T20 1638-1646 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 1726-1754 Disease denotes hypersensitivity pneumonitis http://purl.obolibrary.org/obo/MONDO_0004553|http://purl.obolibrary.org/obo/MONDO_0017853
T23 1726-1742 Disease denotes hypersensitivity http://purl.obolibrary.org/obo/MONDO_0000605|http://purl.obolibrary.org/obo/MONDO_0005271
T25 1743-1754 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T26 1776-1791 Disease denotes viral pneumonia http://purl.obolibrary.org/obo/MONDO_0006012
T27 1782-1791 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T28 1798-1826 Disease denotes Hypersensitivity pneumonitis http://purl.obolibrary.org/obo/MONDO_0004553|http://purl.obolibrary.org/obo/MONDO_0017853
T30 1815-1826 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T31 1828-1830 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T32 1922-1924 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T33 2450-2459 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T34 2553-2555 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T35 2670-2678 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 2701-2705 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T37 2749-2760 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T38 2963-2965 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T39 3211-3219 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 3394-3396 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T41 3703-3705 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T42 3734-3742 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 3826-3828 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T44 3961-3969 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T45 4031-4040 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T46 4049-4057 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T47 4160-4176 Disease denotes Immunodeficiency http://purl.obolibrary.org/obo/MONDO_0021094
T48 4563-4571 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 4701-4719 Disease denotes pulmonary fibrosis http://purl.obolibrary.org/obo/MONDO_0002771
T50 4833-4835 Disease denotes HP http://purl.obolibrary.org/obo/MONDO_0004553
T51 4998-5000 Disease denotes he http://purl.obolibrary.org/obo/MONDO_0017319
T52 5185-5188 Disease denotes HSS http://purl.obolibrary.org/obo/MONDO_0009318
T53 5254-5257 Disease denotes HSS http://purl.obolibrary.org/obo/MONDO_0009318

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 10-11 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 294-306 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T3 332-337 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T4 669-670 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 725-726 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 747-752 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T7 1006-1007 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 1405-1406 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1686-1690 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T10 1686-1690 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T11 1793-1795 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T12 1828-1830 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T13 1828-1830 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T14 1832-1835 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T15 1922-1924 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T16 1922-1924 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T17 2365-2366 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 2385-2388 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T19 2523-2541 http://purl.obolibrary.org/obo/CL_0000815 denotes regulatory T cells
T20 2553-2555 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T21 2553-2555 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T22 2648-2658 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T23 2720-2721 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 2797-2802 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T25 2823-2824 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T26 2963-2965 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T27 2963-2965 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T28 3165-3166 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T29 3242-3243 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T30 3294-3299 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T31 3319-3320 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 3394-3396 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T33 3394-3396 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T34 3397-3400 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T35 3703-3705 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T36 3703-3705 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T37 3826-3828 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T38 3826-3828 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T39 3879-3884 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T40 4154-4159 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Human
T41 4177-4182 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Virus
T42 4421-4426 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T43 4833-4835 http://purl.obolibrary.org/obo/CLO_0003797 denotes HP
T44 4833-4835 http://purl.obolibrary.org/obo/PR_000008725 denotes HP
T45 4855-4857 http://purl.obolibrary.org/obo/CLO_0007653 denotes me
T46 4883-4887 http://www.ebi.ac.uk/efo/EFO_0000827 denotes eyes

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 803-811 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T2 1540-1547 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T3 1828-1830 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T4 1922-1924 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T5 2553-2555 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T6 2963-2965 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T7 3394-3396 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T8 3703-3705 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T9 3826-3828 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055
T10 3870-3877 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T11 4108-4117 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T12 4131-4141 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T13 4142-4152 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T14 4189-4199 Chemical denotes nucleoside http://purl.obolibrary.org/obo/CHEBI_33838
T15 4200-4231 Chemical denotes reverse transcriptase inhibitor http://purl.obolibrary.org/obo/CHEBI_53756|http://purl.obolibrary.org/obo/CHEBI_59897
T17 4208-4231 Chemical denotes transcriptase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T18 4222-4231 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T19 4248-4258 Chemical denotes nucleoside http://purl.obolibrary.org/obo/CHEBI_33838
T20 4259-4290 Chemical denotes reverse transcriptase inhibitor http://purl.obolibrary.org/obo/CHEBI_53756|http://purl.obolibrary.org/obo/CHEBI_59897
T22 4267-4290 Chemical denotes transcriptase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T23 4281-4290 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T24 4300-4322 Chemical denotes HIV protease inhibitor http://purl.obolibrary.org/obo/CHEBI_35660
T25 4304-4322 Chemical denotes protease inhibitor http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T27 4313-4322 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T28 4324-4326 Chemical denotes PI http://purl.obolibrary.org/obo/CHEBI_28874|http://purl.obolibrary.org/obo/CHEBI_53806|http://purl.obolibrary.org/obo/CHEBI_61484|http://purl.obolibrary.org/obo/CHEBI_74790|http://purl.obolibrary.org/obo/CHEBI_37670
T33 4329-4344 Chemical denotes dextran sulfate http://purl.obolibrary.org/obo/CHEBI_34674
T34 4329-4336 Chemical denotes dextran http://purl.obolibrary.org/obo/CHEBI_52071
T35 4337-4344 Chemical denotes sulfate http://purl.obolibrary.org/obo/CHEBI_16189
T36 4509-4516 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T37 4586-4593 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T38 4833-4835 Chemical denotes HP http://purl.obolibrary.org/obo/CHEBI_74055

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 45-61 http://purl.obolibrary.org/obo/GO_0002524 denotes Hypersensitivity
T2 1726-1742 http://purl.obolibrary.org/obo/GO_0002524 denotes hypersensitivity
T3 1798-1814 http://purl.obolibrary.org/obo/GO_0002524 denotes Hypersensitivity
T4 2027-2042 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immunity
T5 2172-2187 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immunity
T6 2601-2616 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immunity
T7 2637-2658 http://purl.obolibrary.org/obo/GO_0006956 denotes complement activation
T8 2926-2936 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T9 2971-2986 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immunity
T10 3553-3565 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T11 3915-3930 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T12 4208-4221 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T13 4208-4221 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T14 4267-4280 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T15 4267-4280 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T16 4776-4794 http://purl.obolibrary.org/obo/GO_0006956 denotes complement cascade

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-73 Sentence denotes COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis
T2 75-327 Sentence denotes The coronavirus disease 2019 (COVID-19) which started in Wuhan, China, and affected most of the country, is spreading rapidly throughout the world in spite of the concerted efforts from the governments and World Health Organization (WHO) to contain it.
T3 328-450 Sentence denotes The virus spreads 1000 times faster than the other viral strains inside the body and causes various kind of illnesses [1].
T4 451-539 Sentence denotes Korea is also adversely affected by COVID-19 due to its geographical proximity to China.
T5 540-753 Sentence denotes Considering the high attack rate and aggressive spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a concern that more serious diseases may develop due to a mutated type of the virus.
T6 754-866 Sentence denotes Some treatment experiences in Korea suggest that steroids played an important role in the treatment of COVID-19.
T7 867-1086 Sentence denotes According to reports from China, although pneumonia was rare in the pediatric population, the risk of pneumonia increased with age and had a high mortality rate among the elderly in their 70s (8.0%) and 80s (14.8%) [2].
T8 1087-1187 Sentence denotes Clinical experiences in Korea (unpublished) and the data from Chinese COVID-19 reports indicate that
T9 1188-1261 Sentence denotes 1) Symptoms were mild and pneumonia was rare in the pediatric population.
T10 1262-1346 Sentence denotes The elderly was more likely to suffer from severe rapidly progressing pneumonia. [2]
T11 1347-1510 Sentence denotes 2) Pneumonia was usually self-limited and resolved within a few weeks in people with normal immune status, but may result in varying degrees of pulmonary fibrosis.
T12 1511-1583 Sentence denotes 3) Usually responded well to steroid treatment (personal communications)
T13 1584-1797 Sentence denotes Radiology and pathology examinations of patients with COVID-19 revealed inflammatory reactions in the lung that resembled what is observed in hypersensitivity pneumonitis rather than in other viral pneumonia [34].
T14 1798-1898 Sentence denotes Hypersensitivity pneumonitis (HP) has three variants, namely, 1) acute, 2) subacute, and 3) chronic.
T15 1899-2022 Sentence denotes The pathophysiology of HP is determined by genetics, environment, age, and immune reactions (both innate and adaptive) [5].
T16 2023-2154 Sentence denotes The innate immunity is robust in the pediatric population while the complement system and adaptive immunity are not mature yet [6].
T17 2155-2272 Sentence denotes In contrast, the innate immunity is not effective while the complement system is increased in the elderly population.
T18 2273-2357 Sentence denotes Adaptive immunity develops from childhood to adulthood, but declines with older age.
T19 2358-2546 Sentence denotes Hence, a healthy adult who has been exposed to seasonal coronaviruses many times may suffer pneumonia due to immune enhancement, which resolves with mobilization of regulatory T cells [78]
T20 2547-2586 Sentence denotes Acute HP is more common in the elderly.
T21 2587-2809 Sentence denotes The defective innate immunity and the accelerated complement activation induced by SARS-CoV-2, similar to that by SARS CoV, leads to a severe rapidly progressing pneumonitis due to the triggering effect of the virus [910].
T22 2810-2966 Sentence denotes In contrast, a healthy adult with normal adaptive immunity controls the inflammatory reaction better through immune regulation and manifests as subacute HP.
T23 2967-3111 Sentence denotes The innate immunity in the pediatric population appears to block the viral invasion at the mucosal level, and results in minimal to no symptoms.
T24 3112-3393 Sentence denotes We believe that there is an urgent need to establish a better sophisticated treatment strategy for COVID-19, because there may be a serious risk owing to the subtle mutations of the virus, which can lead to a more aggressive spread and more severe immunologic reaction in the host.
T25 3394-3513 Sentence denotes HP has been reported in the literature for the past several decades, but its pathophysiology remains poorly understood.
T26 3514-3616 Sentence denotes The possibility of obtaining the exact pathogenesis is less with the current knowledge and technology.
T27 3617-3813 Sentence denotes Considering our current understanding of the pathophysiology and clinical features of HP, the treatment strategy for COVID-19 needs to be tailored according to the patient's age and immune status.
T28 3814-3960 Sentence denotes Traditional HP treatment methods such as decreasing the antigen (virus) and controlling the abnormal immune response must be part of the strategy.
T29 3961-4041 Sentence denotes SARS-CoV-2 is more likely to spread in the elderly and lead to severe pneumonia.
T30 4042-4470 Sentence denotes Hence, COVID-19 patients would benefit from the administration of antiviral medications (nucleotide inhibitors, Human Immunodeficiency Virus (HIV) nucleoside reverse transcriptase inhibitor (NRTI), HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), HIV protease inhibitor (PI), dextran sulfate, and combination therapy, etc.) that will limit the spread of less virulent virus both within the body and in the population.
T31 4471-4720 Sentence denotes Prophylactic and therapeutic low dose steroid oral tablets/inhalers at the earlier stage of COVID-19 and high dose steroid treatment according to the severity of the disease can play important roles in decreasing the fatality and pulmonary fibrosis.
T32 4721-4836 Sentence denotes Additionally, safer treatment options that control the complement cascade could be considered in cases of acute HP.
T33 4837-4905 Sentence denotes God Bless You and me… See the Sky with humble eyes and simple minds.
T34 4907-4988 Sentence denotes Conflicts of Interest: YGS is an editorial board of the journal Infect Chemother.
T35 4989-5092 Sentence denotes However, he did not involve in the reviewer selection, evaluation, and decision making of this article.
T36 5093-5143 Sentence denotes Otherwise, no conflicts of interest were reported.
T37 5144-5165 Sentence denotes Author Contributions:
T38 5166-5189 Sentence denotes Conceptualization: HSS.
T39 5190-5220 Sentence denotes Writing - original draft: YGS.
T40 5221-5258 Sentence denotes Writing - review & editing: YGS, HSS.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 45-73 Phenotype denotes Hypersensitivity Pneumonitis http://purl.obolibrary.org/obo/HP_0006516
T2 909-918 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T3 969-978 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T4 1214-1223 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T5 1332-1341 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T6 1350-1359 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090
T7 1491-1509 Phenotype denotes pulmonary fibrosis http://purl.obolibrary.org/obo/HP_0002206
T8 1726-1754 Phenotype denotes hypersensitivity pneumonitis http://purl.obolibrary.org/obo/HP_0006516
T9 1782-1791 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T10 1798-1826 Phenotype denotes Hypersensitivity pneumonitis http://purl.obolibrary.org/obo/HP_0006516
T11 1828-1830 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T12 1922-1924 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T13 2450-2459 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T14 2553-2555 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T15 2963-2965 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T16 3394-3396 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T17 3703-3705 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T18 3826-3828 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516
T19 4031-4040 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T20 4160-4176 Phenotype denotes Immunodeficiency http://purl.obolibrary.org/obo/HP_0002721
T21 4701-4719 Phenotype denotes pulmonary fibrosis http://purl.obolibrary.org/obo/HP_0002206
T22 4833-4835 Phenotype denotes HP http://purl.obolibrary.org/obo/HP_0006516